| (Values in U.S. Thousands) | Nov, 2020 | Nov, 2019 | Nov, 2018 | Nov, 2017 | Nov, 2016 |
| Sales | 32 | 974 | 186 | 0 | 0 |
| Sales Growth | -96.74% | +423.73% | unch | unch | -100.00% |
| Net Income | -3,204 | -7,127 | -11,856 | -2,387 | -1,109 |
| Net Income Growth | +55.04% | +39.89% | -396.78% | -115.27% | +66.26% |
Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
RISE Life Science Corp is engaged in developing and evolving medical and adult hemp-based formulations to create general use of health and well-being products for the emerging consumer category. It derives key revenue from the United States.
Fiscal Year End Date: 11/30